Skip to content

Specialty Orals

Leading the Way in the Development and Manufacturing of Oral Finished Doses

As a trusted contract development and manufacturing organisation (CDMO), IDT Australia prioritises exceptional quality and regulatory compliance in oral finished dose manufacturing.

Our expertise extends to solid dose oral forms including tablet and capsule formulation as well as liquid dose oral forms facilitated by our state-of-the-art facilities, which are equipped to handle high potency and high containment requirements.

We provide comprehensive support for the development and manufacturing of oral finished doses for pre-clinical and clinical studies ranging from Phase I to Phase III, as well as commercial supply.

IDT has the license and facilities to manufacture a range of medicinal cannabis products for local and international markets.

With a commitment to excellence, IDT stands as a leading manufacturer in the extraction and manufacturing of medicinal cannabis and psychedelics. Our extensive experience in the field, combined with our fully accredited and licensed status as a manufacturer of psychedelic APIs and finished dose forms (S8 & S9), positions us as a trusted partner in this specialised industry.

At IDT, we possess a deep understanding of the intricate process of extracting and purifying botanicals, utilising our expertise to formulate a diverse range of medicinal cannabis products. Our focus on precision and quality ensures that our products meet the highest standards of efficacy and safety.

As a pioneer in the field, IDT acknowledges the therapeutic potential of psychedelics and medicinal cannabis in addressing diverse health conditions. Through strong collaboration with multiple researchers and university partners, we leverage our expertise in extraction, manufacturing, and formulation to advance innovative treatments and therapies, ultimately enhancing the well-being of patients.

IDT Benefits:

  • Validated and Compliant Processes: IDT ensures compliant processes for manufacturing medicinal cannabis and psychedelic products, meeting stringent cGMP and regulatory standards.
  • On-Site Support: Our comprehensive on-site support covers manufacturing, chemistry, microbiological testing, and stability studies. These are all conducted under a robust quality system, ensuring regulatory compliance and seamless coordination.
  • Streamlined Processes: IDT eliminates challenges associated with multiple tech transfers by streamlining product transitions within our expert team, ensuring efficiency, consistency, and minimal delays.
  • Expertise and Quality Assurance: With extensive expertise in manufacturing solid dosage forms for cannabis and psychedelics, our team delivers precise execution of clinical batches, maintaining strict quality standards and regulatory compliance.